NeRRe nabs £20M to test chronic cough drug in patients with a fatal lung disease

NeRRe nabs £20M to test chronic cough drug in patients with a fatal lung disease

Source: 
MedCity News
snippet: 

A NeRRE Therapeutics drug that failed a clinical trial for refractory or unexplained chronic cough is getting a second shot as a potential treatment for chronic cough in patients with idiopathic pulmonary fibrosis, a rare lung disorder. The biotech raised £20M to proceed with Phase 2 testing.